Table of Contents Author Guidelines Submit a Manuscript
International Journal of Alzheimer’s Disease
Volume 2011, Article ID 741974, 15 pages
Review Article

Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value

1Sri Sathya Sai Medical Educational and Research Foundation, Prasanthi Nilayam, 40- Kovai Thirunagar, Coimbatore 641014, India
2Department of Physiology, Faculty of Medicine, Karpagam University, Eachanari, Coimbatore 641021, India
3Department of Anatomy, Yong Loo Lin School of Medicine, Block MD10, Medical Drive, National University of Singapore, Singapore 117597
4Somnogen Inc., College Street, Toronto, ON, Canada M6H 1C5
5Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada M5T 1RS
6Departmento de Docencia e Investigación, Facultad de Ciencias Médicas, Pontificia Universidad Católica Argentina, Avenida Alicia Moreau de Justo 1500, 4° piso, 1107 Buenos Aires, Argentina

Received 21 September 2010; Revised 8 October 2010; Accepted 27 October 2010

Academic Editor: Anthony R. White

Copyright © 2011 Venkatramanujam Srinivasan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Venkatramanujam Srinivasan, Charanjit Kaur, Seithikurippu Pandi-Perumal, Gregory M. Brown, and Daniel P. Cardinali, “Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value,” International Journal of Alzheimer’s Disease, vol. 2011, Article ID 741974, 15 pages, 2011.